뉴스벤징가
Inhibrx Biosciences Plans Head and Neck Cancer Trial Expansion Following High Response Rates
· 발표
기사 요약
Inhibrx Biosciences reports Phase 2 HexAgon trial data showing improved response rates for INBRX-106 in head and neck cancer.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…